Navigation Links
Understanding Sleeping Sickness

espond to infection, the degree of parasite virulence or pathogenicity and the environment.

An IRD team focused particularly on the role of host genetic diversity in response to T. b. gambiense infection (whether or not the disease develops). As human experimentation is excluded, genetic, epidemiological and statistical methods, all brought under the term genetic epidemiology, were developed in order to identify the chromosome regions and/or DNA mutations involved in the development of the disease. The researchers used association techniques in order to determine the influence of certain mutations on the DNA of genes coding for particular immune system proteins (cytokines) in manifestation of the disease. This type of study consists in comparing the frequency of a mutation in subjects with symptoms and in healthy individuals. When the frequency of a mutation is significantly higher in the sick subjects than in the healthy ones, this mutation is associated with an enhanced risk of developing the disease. Conversely, a significantly lower frequency is an expression of a protective effect conferred by the mutation.

The two studies conducted in two distinct foci of the disease, respectively at Sinfra in the Ivory Coast and at Bandundu in the Democratic Republic of Congo (1), revealed evidence of three associations between a DNA mutation and the development of the disease. Depending on their position on certain cytokines genes, the mutations investigated were shown to be capable of inducing in the subject carrying them an increased risk of developing this human trypanosomiasis, or conversely a higher chance of a protector effect (2).

The associations brought out between these mutations and the disease necessitate work to confirm this in different populations and environments. New investigations, particularly in genetic epidemiology, are currently being put into operation in order to check up on possible effects of genetic predisposition
'"/>




Page: 1 2 3

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Restless Legs Syndrome
3. Understanding Lung Cancer Metastasis
4. Understanding The Link Between Hormone Replacement and Respiratory Disease
5. Understanding The Risks Of Hormone Therapy
6. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
7. A Better Understanding Of The Brain Network
8. Understanding The Predictor’s Of Alzheimer’s Diseae
9. Understanding The Harmful Effects Of Radiation Exposure
10. Understanding The Origin Of Tumors
11. Understanding Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Understanding Sleeping Sickness

(Date:9/5/2008)...ane Shows Public Reluctant to Evacuate, Without Th...forts Confirm Survey R...rvey by the American Humane,Association found that...tance if it meant leaving without their family pet...towards the U.S. coast, residents and,officials sh...
(Date:9/5/2008)...swire/ -- Arthrosurface, Inc.,( http://www.arthros...,resurfacing systems, announced that it has receiv... investigation for its line of focal knee,resurfac...tstanding safety,concerns" with the device and gra...n evaluating the safety and efficacy of its,HemiCA...
(Date:9/5/2008)...swire/ -- On Saturday, September 6, PARI,Respirato...k show Today,s,Family as part of their "Breathe Ea...ical device company that provides patients, such a...mpressors that deliver needed,medications directly...es of those affected by respiratory,diseases and t...
(Date:9/5/2008)...ose overweight or obese at age 45 , , FR...ll American adults will develop osteoarthritis of ...y are obese in middle age, a new study says. ,...ncreased as his or her body-mass index (BMI) rose,...Chapel Hill study. People who were of normal weigh...
Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2
... they want to investigate the case of a British ma...s, reports BBC. // Two Sunday newspapers report Sc...iagnosed as HIV-positive in 2002, but found to be ...lsea and Westminster Healthcare NHS Trust, which c...
...po and researchers have found that the habit of be...n to families making it a genetic character. Resea...oin a group which has more social character people...in 8,000 pairs of twins and found that 50 percent ...
...hrough, which could eventually lead to a practical...s, scientists from the US National Cancer Institut... human body to produce chemicals that block HIV in...urs on the surfaces of the gut and reproductive ar...
...h Minister Anbumani Ramadoss on Saturday urged the...n and modernisation of the 80-year-old Communicabl...hennai.// After a visit to the cholera wards in t... that though the doctors in the CDH had been succe...
Other Medicine News:Health News:British man 'Recovered from HIV' 2Health News:Genetically modified bacteria to combat HIV 2Health News:Diligence Of Chennai Doctors Appreciated: Anbumani 2
(Date:9/5/2008)... VIENNA, Va., Sept. 5 /...y that it presented new rheumatoid arthritis data,...n Amsterdam. The data,presented by Dr. Daniel Zim...r Immunology of CEL-SCI, indicate that CEL-SCI,s r...etards the permanent tissue damage,caused by rheum...
(Date:9/5/2008)... MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNews...iversity has shown that U.S. immigrants from,India...country, increasing,their risks of prostate cancer...ales., "Breast cancer and prostate cancer develop...d lifestyle play a major role in these cancers,",s...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /-...t is commencing enrolment for its Phase Ib/II,stud...ng anticancer agent,in patients with an aggressiv...forme (GBM)., The GBM clinical trial is the first... tumor indications for the company and the second ...
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstC...ay announced that the pivotal clinical study of,Po...,s partner, Chemische,Fabrik KREUSSLER & Co. GmbH ...dpoint and has been submitted to FDA as part of a ...al clinical study, named the EASI (Efficacy and sa...
Breaking Medicine Technology:Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 1Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 2Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 3Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 4Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 5BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 1BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 2California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 1California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 1GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 3
...ization and drug withdrawal, CHICAGO, May 15, 2007...ine patients and physicians commissioned by the Na... Interactive shows that,20 percent of migraine pat...edications that contain barbiturates or opioids an... Administration for the,relief of migraines. , Mig...
... of clinical data on leading,drug-eluting stent po...irstCall/ -- Boston,Scientific Corporation today a...s and press announcements at the annual Paris,Cour... from May 22,to 25 in Barcelona, Spain. , "We will...al,trials and registries, adding to the knowledge ...
Other Medicine Technology:Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 2Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 3Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 4Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 5Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 6Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours.
...eg; Thermovent® T helps provide protection to ... is small and extremely lightweight making it idea...h a high rate of heat and moisture recovery, it en...ion., ,All HMEs and filters have ISO standard tap...
Medicine Products: